Moderna’s COVID Vaccine Could Be Better Than Pfizer’s — Here’s Why Its Stock Isn’t
There are a couple of big reasons why Moderna stock isn’t as good of a pick as Pfizer right now.
There are a couple of big reasons why Moderna stock isn’t as good of a pick as Pfizer right now.
The outcome of the U.S. Federal Reserve’s policy meeting and the possible collapse of the Chinese real estate conglomerate Evergrande…
GARCHING, Germany & MUNICH–(BUSINESS WIRE)–ITM, a leading radiopharmaceutical biotech company, announced today with the registration…
Oxford Industries has seen significant rebound from 2020 lows. Here’s why I believe that there could be further upside if sales…
Dublin, Sept. 22, 2021 (GLOBE NEWSWIRE) — The “US Bathroom Organization Products Market 2021-2025” report has been added to…
Evergrande’s main unit Hengda Real Estate Group will make coupon payment on onshore bonds after successful private negotiations…
BASEL, Switzerland, Sept. 22, 2021 /PRNewswire/ — BaseLaunch, the Basel Area-based biotech venture accelerator and incubator,…
Federal Realty Investment is a quality REIT prospect and is well diversified. When you consider EV to EBITDA multiple, FRT is…
Indiabulls Real Estate, Sobha, Prestige Estates, Oberoi Realty, Sunteck Realty, Mahindra Lifespace and Macrotech Developers were…
Lear Corporation (NYSE: LEA), a global automotive technology leader in Seating and E-Systems, today announced it has signed a…